![](/img/cover-not-exists.png)
C3-03: Randomized, phase III Study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (TRT) for unresectable stage III non-small-cell lung cancer (NSCLC): WJTOG0105
Yoshida, Kimihide, Uejima, Hisao, Satouchi, Miyako, Kudoh, Shinzoh, Nakagawa, Kazuhiko, Hida, Toyoaki, Kawahara, Masaaki, Sugiura, Takamune, Tamura, Kenji, Fukuoka, MasahiroVolume:
2
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.jto.0000283204.17566.c5
Date:
August, 2007
File:
PDF, 174 KB
english, 2007